High constitutive activity of native H3 receptors regulates histamine neurons in brain

[1]  J. Schwartz,et al.  Cloning and cerebral expression of the guinea pig histamine H3 receptor: evidence for two isoforms , 2000, Neuroreport.

[2]  J. Black,et al.  Evidence that histamine homologues discriminate between H3‐receptors in guinea‐pig cerebral cortex and ileum longitudinal muscle myenteric plexus , 1999, British journal of pharmacology.

[3]  J. Schwartz,et al.  Novel partial agonists for the histamine H(3) receptor with high in vitro and in vivo activity. , 1999, Journal of medicinal chemistry.

[4]  M. Jackson,et al.  Cloning and functional expression of the human histamine H3 receptor. , 1999, Molecular pharmacology.

[5]  S. Maayani,et al.  Novel actions of inverse agonists on 5-HT2C receptor systems. , 1999, Molecular pharmacology.

[6]  J. Bockaert,et al.  Novel brain-specific 5-HT4 receptor splice variants show marked constitutive activity: role of the C-terminal intracellular domain. , 1999, Molecular pharmacology.

[7]  S. L. Yates,et al.  Effects of selected histamine H3 receptor antagonists on tele-methylhistamine levels in rat cerebral cortex. , 1999, Biochemical pharmacology.

[8]  J. Schwartz,et al.  Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist. , 1998, The Journal of pharmacology and experimental therapeutics.

[9]  P. H. Schiller,et al.  The effects of frontal eye field and dorsomedial frontal cortex lesions on visually guided eye movements , 1998, Nature Neuroscience.

[10]  C. Braun,et al.  Event-Related Brain Potentials Following Incorrect Feedback in a Time-Estimation Task: Evidence for a Generic Neural System for Error Detection , 1997, Journal of Cognitive Neuroscience.

[11]  H. Haas,et al.  International Union of Pharmacology. XIII. Classification of histamine receptors. , 1997, Pharmacological reviews.

[12]  J. Schall,et al.  Neural Control of Voluntary Movement Initiation , 1996, Science.

[13]  R. Leurs,et al.  Inverse agonism of histamine H2 antagonist accounts for upregulation of spontaneously active histamine H2 receptors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Hill,et al.  Sensitivity of histamine H3 receptor agonist-stimulated [35S]GTPγ[S]binding to pertussis toxin , 1996 .

[15]  M. Coles,et al.  Where did you go wrong? Errors, partial errors, and the nature of human information processing. , 1995, Acta psychologica.

[16]  J. Schall,et al.  Countermanding saccades in macaque , 1995, Visual Neuroscience.

[17]  T. Kenakin,et al.  Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the β2-adrenoceptor , 1995, Nature.

[18]  S. Wise,et al.  Neuronal activity in the supplementary eye field during acquisition of conditional oculomotor associations. , 1995, Journal of neurophysiology.

[19]  S. Hill,et al.  Differential effect of sodium ions and guanine nucleotides on the binding of thioperamide and clobenpropit to histamine H3‐receptors in rat cerebral cortical membranes , 1995, British journal of pharmacology.

[20]  J. Schwartz,et al.  [125I]iodoproxyfan, a new antagonist to label and visualize cerebral histamine H3 receptors. , 1994, The Journal of pharmacology and experimental therapeutics.

[21]  M. Posner,et al.  Localization of a Neural System for Error Detection and Compensation , 1994 .

[22]  D. Meyer,et al.  A Neural System for Error Detection and Compensation , 1993 .

[23]  J. Parma,et al.  Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas , 1993, Nature.

[24]  R. Lefkowitz,et al.  Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. , 1993, Trends in pharmacological sciences.

[25]  R. Lefkowitz,et al.  A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. , 1993, The Journal of biological chemistry.

[26]  J. Schwartz,et al.  S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist. , 1992, The Journal of pharmacology and experimental therapeutics.

[27]  D Rodbard,et al.  Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand. , 1992, Molecular pharmacology.

[28]  M. Caron,et al.  Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. , 1992, The Journal of biological chemistry.

[29]  J. Schall,et al.  Neuronal activity related to visually guided saccadic eye movements in the supplementary motor area of rhesus monkeys. , 1991, Journal of neurophysiology.

[30]  R. Egan,et al.  Identification of two H3-histamine receptor subtypes. , 1990, Molecular pharmacology.

[31]  M. Martres,et al.  Alternative splicing directs the expression of two D2 dopamine receptor isoforms , 1989, Nature.

[32]  C. Gerfen,et al.  Multiple D2 dopamine receptors produced by alternative RNA splicing , 1989, Nature.

[33]  J. Schwartz,et al.  Effects of histamine H3-receptor ligands on various biochemical indices of histaminergic neuron activity in rat brain. , 1989, European journal of pharmacology.

[34]  J. Schwartz,et al.  Autoinhibition of histamine synthesis mediated by presynaptic H3-receptors , 1987, Neuroscience.

[35]  J. Schwartz,et al.  Highly potent and selective ligands for histamine H3-receptors , 1987, Nature.

[36]  G. Logan.  Executive control of thought and action , 1985 .

[37]  J. Schwartz,et al.  Autoregulation of histamine release in brain by presynaptic H3-receptors , 1985, Neuroscience.

[38]  G. Logan.  On the ability to inhibit thought and action , 1984 .

[39]  J. Schwartz,et al.  Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor , 1983, Nature.

[40]  Masataka Watanabe,et al.  Prefrontal and cingulate unit activity during timing behavior in the monkey , 1979, Brain Research.

[41]  A. Dickinson,et al.  Neuronal coding of prediction errors. , 2000, Annual review of neuroscience.

[42]  M. Botvinick,et al.  The Contribution of the Anterior Cingulate Cortex to Executive Processes in Cognition , 1999, Reviews in the neurosciences.

[43]  A. Spiegel,et al.  Defects in G protein-coupled signal transduction in human disease. , 1996, Annual review of physiology.

[44]  G. Milligan,et al.  Inverse agonism: pharmacological curiosity or potential therapeutic strategy? , 1995, Trends in pharmacological sciences.

[45]  J. Hohnsbein,et al.  Late ERP components in visual and auditory Go/Nogo tasks. , 1995, Electroencephalography and clinical neurophysiology.

[46]  W. Schütz,et al.  Reverse intrinsic activity of antagonists on G protein-coupled receptors. , 1992, Trends in pharmacological sciences.